• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
    • Dynamic Chiropractic
      • Newspaper
      • Subscription
    • The American Chiropractor
      • Magazine
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Sponsored Content
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
    • Coronavirus (COVID-19)
  • Resource Centers
  • Products & Services
    • Buyers Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students

Study shows BCM-95 curcumin more effective than placebo in treating major depression

Chiropractic Economics August 15, 2014

465552417August 15, 2014 — A recently published clinical trial on major depressive disorder showed that high absorption BCM-95 curcumin was more effective in improving depression symptoms compared to placebo.1

In a randomized, double-blind, placebo-controlled trial, 56 individuals diagnosed with major depressive disorder were treated with BCM-95 curcumin (500 mg twice daily) or placebo for eight weeks. Researchers utilized clinically-validated scales of self-reported inventories for depression assessment. Each week participants were asked to rate the severity and frequency of specific symptoms present over the past seven days for eight weeks total.

By week four, continuing through week eight, BCM-95 curcumin was significantly more effective than placebo in lowering self-reported depressive and anxiety symptoms. When examining the effects of curcumin in people with atypical depression, which is generally more difficult to treat, BCM-95 curcumin had even greater antidepressant and anti-anxiety efficacy compared to placebo.

“An important finding from this study is the enhanced antidepressant and anxiolytic efficacy of curcumin in people with atypical depression,” the authors noted.

Atypical depression is often associated with higher levels of inflammation. The researchers theorized that the anti-inflammatory effects of curcumin may account for its increased effectiveness in this group.

“There is now increasing support for the antidepressant effects of curcumin, with a previous study2 demonstrating BCM-95 curcumin to be as effective as a pharmaceutical antidepressant for the treatment of depression,” Dr. Adrian Lopresti, lead author of the study, said. “Further larger clinical trials are required to determine the optimal treatment dosage, length of treatment, and long-term efficacy of curcumin.”

It is important to note that the form of curcumin used in the study, BCM-95 curcumin, has unique specifications, including high absorption and inclusion of turmeric essential oil, which is not found in standard curcumin. Therefore, results may not apply to other forms of curcumin.

For more information on the study, please contact Dean Draznin Communications at 641-209-9591 641-209-9591.

References

1Lopresti A, Maes M, Maker G, Hood S, Drummond P. Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders. June 1, 2014. Available at: http://dx.doi.org/10.1016/j.jad.2014.06.001

2Sanmukhani J, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. July 6, 2013.

 

Source: Dean Draznin Communications

Related Posts

  • EHRs: Benefits, ROIs and your systemEHRs: Benefits, ROIs and your system
  • Are you Medicare compliant?Are you Medicare compliant?
  • Dick Gephardt to headline NCLC 2010Dick Gephardt to headline NCLC 2010
  • Disability increasing among older obese individualsDisability increasing among older obese individuals
  • NYCC’s Master of Science in Human Anatomy and Physiology Instruction approvedNYCC’s Master of Science in Human Anatomy and Physiology Instruction approved
  • National Handwashing Awareness week: Why it matters to DCsNational Handwashing Awareness week: Why it matters to DCs

Filed Under: Industry News, News

Current Issue

CE issue 15 cover

Follow Us

  • Facebook
  • X (Twitter)
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

Compare Subscriptions

Dynamic Chiropractic

The American Chiropractor

3948 3rd Street South #279,

Jacksonville Beach, FL 32250

Phone 904-285-6020

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2023, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • National Chiropractic Health Month to raise awareness of non-drug pain relief
  • ICA launches TV campaign on chiropractic’s 128th anniversary
  • Study unveils relationship between chiropractic care and immune response